cGMP-compliant high-yield automated production of [18F]AlF-FAPI-74: optimization of quality control and evaluation of molar dose impact
Abstract Background Fibroblast activation protein inhibitor (FAPI)-based positron emission tomography (PET) radiopharmaceuticals have shown promise for imaging cancer-associated fibroblasts (CAFs), a key component of the tumor microenvironment. FAPI radiopharmaceuticals offer high tumor-to-backgroun...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| 格式: | Artigo |
| 语言: | Inglês |
| 出版: |
SpringerOpen
2025-12-01
|
| 丛编: | EJNMMI Radiopharmacy and Chemistry |
| 主题: | |
| 在线阅读: | https://doi.org/10.1186/s41181-025-00411-1 |
| 标签: |
没有标签, 成为第一个标记此记录!
|
